Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immuneering Corp Cl A 245 MAIN STREET SECOND FLOOR CAMBRIDGE MA 02142 USA

www.immuneering.com Employees: 66 P: 617-500-8080

Sector:

Medical

Description:

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 324,141
Enterprise Value, $K 288,001
Shares Outstanding, K 64,570
Float, K 49,783
% Float 77.10%
Short Interest, K 11,201
Short Float 17.35%
Days to Cover 2.47
Short Volume Ratio 0.57
% of Insider Shareholders 22.90%
% of Institutional Shareholders 67.65%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -61,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,960 K
EBIT, $ -64,150 K
EBITDA, $ -63,700 K

Growth:

1-Year Return 180.56%
3-Year Return 10.02%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 11/12/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.78
EPS Growth vs. Prev Qtr 5.00%
EPS Growth vs. Prev Year 22.45%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IMRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.49%
Return-on-Assets % -65.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.38
Book Value/Share 3.59
Interest Coverage -2.80
60-Month Beta 0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar